Rankings
▼
Calendar
RVMD Q4 2025 Earnings — Revolution Medicines, Inc. Revenue & Financial Results | Market Cap Arena
RVMD
Revolution Medicines, Inc.
$20B
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$5M
Operating Income
-$362M
Net Income
-$365M
EPS (Diluted)
$-1.90
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$274M
Free Cash Flow
-$276M
Stock-Based Comp.
$34M
Balance Sheet
Total Assets
$2.4B
Total Liabilities
$723M
Stockholders' Equity
$1.6B
Cash & Equivalents
$384M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$5M
$0
—
Operating Income
-$362M
-$216M
-67.2%
Net Income
-$365M
-$195M
-87.5%
← FY 2025
All Quarters